查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553511

治疗药物监测市场规模、份额和趋势分析报告：按产品、药物类别、最终用途、地区和细分市场预测，2024-2030

Therapeutic Drug Monitoring Market Size, Share & Trends Analysis Report By Product (Equipment, Consumables), By Drug Class (Antiarrhythmic Drugs), By End Use (Diagnostic Centers), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

治疗药物监测市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球治疗药物监测市场规模将达23.2亿美元，2024年至2030年复合年增长率为3.8%。

即时护理 (PoC) 设备的最新技术进步有可能彻底改变个人化、预测性和预防性医疗保健。治疗药物监测（TDM）是製定患者定制治疗计划的基本组成部分，而能够定量测量药物浓度的PoC诊断设备的出现是医疗保健领域精准化的重要一步，在支持方面发挥着极其重要的作用。领域的发展。然而，PoC设备在病患监测中的广泛应用仍然滞后。这种开拓的机会的存在是市场成长的重要驱动力之一。

在器官移植后给药方案的早期阶段采用连续治疗药物和代谢物监测是重症患者医学和器官移植领域的主要应用，预计将在预测期内推动治疗药物监测市场。此外，癫痫和癌症等疾病负担的增加、政府倡议的增加以及未满足的需求较高是预计将进一步推动该市场出现的一些关键决定因素。

治疗药物监测市场报告亮点

  • 2023年，消耗品领域占市场占有率超过65.4%。这是实验室对耗材的大量需求以及套件和试剂的重复购买的结果。
  • 预计免疫抑制剂领域成长最快，在预测期内年复合成长率为 5.3%。
  • 2023年的市场占有率由医院领域主导。大型医院采用各种基本技术来进行免疫测量。这些包括化学冷光、比浊法、比色法和萤光，可用于测试多种药物。
  • 随着新的 TDM就地检验设备的引入，免疫抑制剂的治疗药物监测成为成长最快的应用之一，以评估所施用的免疫抑制剂及其代谢物的浓度。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章治疗药物监测市场变数、趋势和范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 治疗药物监测市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 治疗药物监测市场：依产品估计和趋势分析

  • 细分仪表板
  • 治疗药物监测市场：2024 年和 2030 年按产品分類的变异分析
  • 装置
  • 消耗品

第五章治疗药物监测市场：依药物类别估计与趋势分析

  • 细分仪表板
  • 治疗药物监测市场：2024 年和 2030 年药物类别变化分析
  • 抗心律不整药物
  • 免疫抑制剂
  • 抗癫痫药
  • 其他的

第六章 治疗药物监测市场：依最终用途分类的估计与趋势分析

  • 细分仪表板
  • 治疗药物监测市场：2024 年和 2030 年最终用途的变化分析
  • 医院
  • 诊断中心
  • 其他的

第七章 治疗药物监测市场：区域估计与趋势分析

  • 2024 年及 2030 年治疗药物监测市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Abbott
    • ALPCO
    • Beckman Coulter, Inc
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Chromsystems Instruments &Chemicals GmbH
    • F.Hoffmann-La Roche Ltd.
    • Randox laboratories Ltd
    • Siemens Healthineers AG.
    • biomerieux, Inc.
简介目录
Product Code: GVR-1-68038-032-3

Therapeutic Drug Monitoring Market Growth & Trends:

The global therapeutic drug monitoring market size is estimated to reach USD 2.32 billion by 2030, expanding at a CAGR of 3.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Recent technological advancements in the Point-of-Care (PoC) devices hold considerable transformative promises for the personalized predictive and preventive medicine. Therapeutic Drug Monitoring (TDM) forms a foundational part to the devising of personalized treatment plans for patients; and the advent of PoC diagnostic devices that yield quantitative measurements of the drug concentration plays a pivotal role in supporting the development of the precision medicine field in the healthcare sector. However, the broad application of the PoC devices for patient monitoring is still lagging behind. The presence of this untapped opportunity is one of the high impact rendering drivers for the market growth.

The employment of continuous therapeutic drug and metabolite monitoring in the early phase of the medication regimen, administered post-organ transplantation, forms a major application in the areas of critical care medicine and organ transplantation, which is expected to propel the growth of the therapeutic drug monitoring market over the forecast period. In addition, the imposing burden of diseases, such as epilepsy and cancer, the rising government initiatives, and the presence of high-unmet needs are some of the crucial determinants expected to further favor the emergence of this market.

Therapeutic Drug Monitoring Market Report Highlights:

  • The consumables segment covered over 65.4% of the market share in 2023 as a consequence of the extensive requirement of the consumables in the research laboratories and due to the repeat purchase of the kits and reagents.
  • The immunosuppressants segment is expected to grow fastest, with a compounded annual growth rate of 5.3% over the forecast period.
  • The hospital segment dominated the market share in 2023. In larger hospitals, various underlying technologies are employed to perform immunoassays; these comprise chemiluminescence, nephelometry, colorimetry, and fluorescence, which are available for the testing of a wide ranging drug panel.
  • The drug monitoring for the immunosuppressants is one of the fastest growing application segments owing to the introduction of novel TDM point-of-care testing devices for the evaluation of the concentration of administered immunosuppressants and the complementary metabolites, in order to achieve a prominent therapeutic effect while preventing drug toxicity events in patients that have undergone transplantations.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Therapeutic Drug Monitoring Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Therapeutic Drug Monitoring Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Therapeutic Drug Monitoring Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Therapeutic Drug Monitoring Market: Product Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Equipment
    • 4.3.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Immunoassay Analyzers
      • 4.3.2.1. Immunoassay Analyzers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Clinical Chemistry Analyzers
      • 4.3.3.1. Clinical Chemistry Analyzers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Chromatography & MS detectors
      • 4.3.4.1. Chromatography & MS detectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Therapeutic Drug Monitoring Market: Drug Class Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Therapeutic Drug Monitoring Market: Drug Class Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Antiarrhythmic Drugs
    • 5.3.1. Antiarrhythmic Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Immunosuppressants
    • 5.4.1. Immunosuppressants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Antiepileptic Drugs
    • 5.5.1. Antiepileptic Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Therapeutic Drug Monitoring Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Therapeutic Drug Monitoring Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Diagnostic Centers
    • 6.4.1. Diagnostics Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Therapeutic Drug Monitoring Market: Regional Estimates & Trend Analysis

  • 7.1. Therapeutic Drug Monitoring Market Share, By Region, 2024 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. China Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Australia Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. South Korea Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. ALPCO
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Beckman Coulter, Inc
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Bio-Rad Laboratories, Inc.
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Thermo Fisher Scientific Inc.
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Chromsystems Instruments & Chemicals GmbH
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. F.Hoffmann-La Roche Ltd.
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Randox laboratories Ltd
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Siemens Healthineers AG.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. biomerieux, Inc.
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives